Structure-based maximal affinity model predicts small-molecule druggability
- PMID: 17211405
- DOI: 10.1038/nbt1273
Structure-based maximal affinity model predicts small-molecule druggability
Abstract
Lead generation is a major hurdle in small-molecule drug discovery, with an estimated 60% of projects failing from lack of lead matter or difficulty in optimizing leads for drug-like properties. It would be valuable to identify these less-druggable targets before incurring substantial expenditure and effort. Here we show that a model-based approach using basic biophysical principles yields good prediction of druggability based solely on the crystal structure of the target binding site. We quantitatively estimate the maximal affinity achievable by a drug-like molecule, and we show that these calculated values correlate with drug discovery outcomes. We experimentally test two predictions using high-throughput screening of a diverse compound collection. The collective results highlight the utility of our approach as well as strategies for tackling difficult targets.
Similar articles
-
Binding site detection and druggability index from first principles.J Med Chem. 2009 Apr 23;52(8):2363-71. doi: 10.1021/jm801385d. J Med Chem. 2009. PMID: 19296650
-
Druggability indices for protein targets derived from NMR-based screening data.J Med Chem. 2005 Apr 7;48(7):2518-25. doi: 10.1021/jm049131r. J Med Chem. 2005. PMID: 15801841
-
Form follows function: shape analysis of protein cavities for receptor-based drug design.Proteomics. 2009 Jan;9(2):451-9. doi: 10.1002/pmic.200800092. Proteomics. 2009. PMID: 19142949
-
Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.Curr Opin Chem Biol. 2011 Aug;15(4):463-8. doi: 10.1016/j.cbpa.2011.05.020. Epub 2011 Jun 23. Curr Opin Chem Biol. 2011. PMID: 21704549 Review.
-
Informatics and modeling challenges in fragment-based drug discovery.Curr Opin Drug Discov Devel. 2007 May;10(3):289-97. Curr Opin Drug Discov Devel. 2007. PMID: 17554855 Review.
Cited by
-
Pocket-based drug design: exploring pocket space.AAPS J. 2013 Jan;15(1):228-41. doi: 10.1208/s12248-012-9426-6. Epub 2012 Nov 22. AAPS J. 2013. PMID: 23180158 Free PMC article. Review.
-
Predicting DNA binding protein-drug interactions based on network similarity.BMC Bioinformatics. 2020 Jul 20;21(1):322. doi: 10.1186/s12859-020-03664-6. BMC Bioinformatics. 2020. PMID: 32689927 Free PMC article.
-
Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.J Med Chem. 2022 Sep 22;65(18):12240-12255. doi: 10.1021/acs.jmedchem.2c00946. Epub 2022 Sep 6. J Med Chem. 2022. PMID: 36066412 Free PMC article.
-
Predicting drug-target interactions using restricted Boltzmann machines.Bioinformatics. 2013 Jul 1;29(13):i126-34. doi: 10.1093/bioinformatics/btt234. Bioinformatics. 2013. PMID: 23812976 Free PMC article.
-
A Guide to In Silico Drug Design.Pharmaceutics. 2022 Dec 23;15(1):49. doi: 10.3390/pharmaceutics15010049. Pharmaceutics. 2022. PMID: 36678678 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical